Moderna, Immatics join hands to hunt for cancer therapies using mRNA, AI
HQ Team September 11, 2023: Moderna Inc. announced a pact with Immatics NV, a clinical-stage biopharmaceutical company, to develop cancer therapies using a
HQ Team September 11, 2023: Moderna Inc. announced a pact with Immatics NV, a clinical-stage biopharmaceutical company, to develop cancer therapies using a
HQ Team Sept 11, 2023: A new US research study has found a connection between the environment a child is raised in and
HQ Team September 11, 2023: A total of 34 confirmed cases of the COVID-19 virus variant, BA.2.86, have been identified in the UK,
HQ Team September 11, 2023: An electronic device to endlessly monitor a transplanted organ’s temperature, to detect signs of the body’s rejection, has
HQ Team September 8, 2023: If you are an unmarried male, the chances of finding a female partner in the US are stacked
HQ Team September 7, 2023: Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to
HQ Team September 7, 2023: Extreme heat due to climate change, combined with wildfires and desert dust, is having a pernicious effect on
HQ Team September 6, 2023: About 330,000 migrants and refugees continue to cross the dense tropical jungle between Colombia and Panama risking their
HQ Team September 6, 2023: The global marine industry is pulling out six billion tons of sand and sediments, a non-renewable resource, from
HQ Team September 6, 2023: Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in